Imagine a program that takes the hassle out of patient travel within a clinical trial. When dealing with a condition of any sort, be it rare or otherwise, asking a patient to travel across state lines or even to another country, can be a source of anxiety and for many, a financial hardship. Many rare diseases especially, affect newborns who require a parent or guardian to handle travel logistics and accompany the patient. In many instances, travel can affect an entire family not once, but for multiple site visits throughout the course of a study. If not the patients themselves, many parents, guardians or caregivers determine that the complexity involved in getting to a site might outweigh the benefits of participation in a clinical trial. But what if the burden associated with travel could be eliminated?